99.86 127.96 172.00 189.98 206.00 224.02 281.12 325.06 307.10 307.16 281.11 206.04 224.02 190.02 171.95 145.95 146.01 128.00 99.97 m/z Relative abundance.

Slides:



Advertisements
Similar presentations
The molecular formula is C 5 H 8. What is the structure?
Advertisements

Scaffold Download free viewer:
Supplemental figure 1. The structures of the wild-type (left) and aberrant Man5GlcNAc2 N-glycan (right) is shown.
Supplement material to Ref. JASMS Ms. No Detection of an amine impurity and quality assessment related to this impurity of the UV MALDI matrix.
Supplemental Figures, for reviews only. MNV RdRp RNA Formadehyde MNV RdRp+ PS, X-link MNV RdRp+ Hp, X-link MNV RdRp+ PS, no X-link MNV RdRp+ Hp, no X-link.
1. Synthesis of selenated hydroxy fatty acids BRASINOE U.
A B C Figure S1. LC-MS and LC-MS/MS data on [M+H]+ ion with 837 m/z formed when MDI is reacted with oxidized glutathione. Following reactivity of MDI with.
Supplemental figures. Observed extracted ion chromatograms (XICs) of each of the ten peptides from five standard proteins using dual ion funnel and standard.
Chapter 15 Structure Determination by Spectroscopy (II): UV-Vis & Mass
The use of cyclohexanone as a “derivatizing” reagent for the GC–MS detection of amphetamines and ephedrines in seizures and the urine  B.M. El-Haj, A.M.
Supplemental Data Figure 4: Reverse phase-HPLC of extracts from coronary sinus and femoral artery plasma from subject 6. Each fraction was assayed with.
Supplemental Data Figure 1: Reverse phase-HPLC of atrial extract from subject 3. Each fraction was assayed with three separate immunoassays: N-terminal.
Supplemental Data Figure 2: Reverse phase-HPLC of ventricle extract from subject 3. Each fraction was assayed with three separate immunoassays: N-terminal.
Supplemental Data Figure 3: Reverse phase-HPLC of peripheral venous plasma extract from subject 3. Each fraction was assayed with two separate immunoassays:
Volume 26, Issue 1, Pages (April 2007)
Volume 12, Issue 10, Pages (October 2005)
(A) (E) (B) (C) (F) (D) Control HLM MLM Chemical synthesis M6
MS Review.
Volume 17, Issue 2, Pages (February 2009)
Hirotaka Matsui, Hiroya Asou, Toshiya Inaba  Molecular Cell 
(A) (E) (B) (C) (F) (D) Control HLM MLM Chemical synthesis M2 M2'
Proteomics Informatics David Fenyő
Volume 20, Issue 10, Pages (October 2013)
Volume 138, Issue 4, Pages (August 2009)
Volume 23, Issue 10, Pages (October 2015)
Volume 19, Issue 8, Pages (August 2011)
Volume 15, Issue 2, Pages (February 2008)
Interpretation of Mass Spectra I
Volume 124, Issue 6, Pages (March 2006)
Volume 17, Issue 4, Pages (April 2009)
A Patient With Hereditary ATTR and a Novel AGel p
(A) (E) (B) (C) (F) (D) Control HLM MLM Chemical synthesis M4 M4'
(E) (A) (B) (C) (F) (D) Control HLM MLM Chemical synthesis M3'' M3'''
Volume 47, Issue 1, Pages (July 2012)
Volume 15, Issue 5, Pages (September 2004)
The molecular network of the fungal molecule asperphenamate (m/z 507
Volume 20, Issue 12, Pages (December 2013)
A, high resolution MS/MS spectrum (lower panel) of 1435
Supplemental Figure 3 A B C T-DNA 1 2 RGLG1 2329bp 3 T-DNA 1 2 RGLG2
Glucose repression/derepression in budding yeast: SNF1 protein kinase is activated by phosphorylation under derepressing conditions, and this correlates.
On the Distribution of Protein Refractive Index Increments
Rachel L Winston, Joel M Gottesfeld  Chemistry & Biology 
The Arginine-Rich RNA-Binding Motif of HIV-1 Rev Is Intrinsically Disordered and Folds upon RRE Binding  Fabio Casu, Brendan M. Duggan, Mirko Hennig 
Volume 114, Issue 5, Pages (March 2018)
Johnson Cheung, Michael E.P. Murphy, David E. Heinrichs 
MS/MS spectra of INEILSNALKR with a Lys residue modified with SUMO1 or SUMO3 remnant chains. MS/MS spectra of INEILSNALKR with a Lys residue modified with.
Volume 1, Issue 1, Pages (January 2008)
2D-LC-MS/MS analysis of tryptic digest of HEK293-SUMO3 cells (2 μg inj
Comparisons of MS/MS ion fragmentation spectra derived from GNPS network annotations (see Table S4 posted at ftp://massive.ucsd.edu/MSV /updates/ _aedlund_ /other/)
Volume 21, Issue 6, Pages (June 2013)
Volume 26, Issue 1, Pages (April 2007)
Pritam Chanda, Aidong Zhang, Daniel Brazeau, Lara Sucheston, Jo L
Tandem Enzymatic Oxygenations in Biosynthesis of Epoxyquinone Pharmacophore of Manumycin-type Metabolites  Zhe Rui, Moriah Sandy, Brian Jung, Wenjun Zhang 
Volume 122, Issue 2, Pages (July 2005)
Functional Assembly of AMPA and Kainate Receptors Is Mediated by Several Discrete Protein-Protein Interactions  Gai Ayalon, Yael Stern-Bach  Neuron  Volume.
One Enzyme, Three Metabolites: Shewanella algae Controls Siderophore Production via the Cellular Substrate Pool  Sina Rütschlin, Sandra Gunesch, Thomas.
Volume 23, Issue 2, Pages (February 2016)
Volume 95, Issue 3, Pages (August 2008)
Volume 13, Issue 4, Pages (April 2013)
Volume 4, Issue 2, Pages (March 2011)
Volume 112, Issue 8, Pages (April 2017)
Volume 19, Issue 8, Pages (August 2011)
Functional metabolic rearrangements in chloramphenicol‐resistant populations Functional metabolic rearrangements in chloramphenicol‐resistant populations.
Volume 17, Issue 4, Pages (February 2005)
Interpretation of Mass Spectra
NMR Structures of the Second Transmembrane Domain of the Human Glycine Receptor α1 Subunit: Model of Pore Architecture and Channel Gating  Pei Tang, Pravat.
Volume 27, Issue 7, Pages e5 (July 2019)
Time-Resolved NMR: Extracting the Topology of Complex Enzyme Networks
Time-Resolved NMR: Extracting the Topology of Complex Enzyme Networks
A Delocalized Proton-Binding Site within a Membrane Protein
Presentation transcript:

m/z Relative abundance Reference spectrum [M+H] + Acquired spectrum Supplemental Figure 1. Identification of enantio-pyochelin. Top panel: MS/MS spectrum for the [M+H] + ion identified as enantio-pyochelin, bottom panel: reference MS/MS spectrum of pyochelin from GNPS database

Supplemental Figure 2A. LC-MS-analysis of the 2 nd size exclusion fraction of the XAD-4 crude extract of P. fluorescens BBc6R8. The middle panel shows the extracted UV-chromatogram ( nm) with four groups of pyoverdine congeners. The peaks of the four main groups are color-coded correlated with the observed quasi molecular ion [M+H] + peak in the corresponding mass spectra recorded at the same time (top and bottom panels). Abbreviations: Pyo = pyoverdine; Glu = glutamic acid; Suc = succinic acid; Suca = succinic acid amide; Mal = malic acid; Kgl = alpha-ketoglutaric acid. Pyo-Suc Pyo-Kgl Pyo-Glu Pyo-Suca Pyo-Mal

Supplemental Figure 2B. Extracted UV-Spectra from the identified pyoverdine derivatives. The color code refers to the peaks marked in Figure 2A. R = peptide moiety of the Pf-BBc6R8-pyoverdine. Abbreviations: Pyo = pyoverdine; Glu = glutamic acid; Suc = succinic acid; Suca = succinic acid amide; Mal = malic acid; Kgl = alpha-ketoglutaric acid. Pyo-Mal Pyo-Suca Pyo-Glu Pyo-Suc Pyo-Kgl

Supplemental Figure 3. HR-ESI-TOF-MS of viscosin. Bottom panel: measured HR-MS [M+Na] + m/z Top panel: calculated HR-MS spectrum for the formula C 54 H 95 N 9 O 16 Na, the theoretical pseudomolecular ion of viscosin ( , Δ +0.8 ppm)

Supplemental Figure 4. Result of the white line agar assay demonstrating that the biosurfactant produced by P. fluorescens BBc6R8 is viscosin. A. White line agar assay between P. tolaasii and P. reactans (WLIP producer). The arrow points at the white line indicating the production of WLIP by P. reactans. B. White line agar assay between P. tolaasii and P. fluorescens SBW25 (viscosin producer). C.. White line agar assay between P. tolaasii and P. fluorescens BBc6R8 A B C

Supplemental Figure 5. 1 H NMR spectrum of viscosin (250 MHz, d 4 -MeOH).

Supplemental Fig 6. Effect of P. fluorescens BBc6R8 WT and of the mutant ∆viscB -P448 on the radial growth of L. bicolor S238N on KB agar medium. Similar result was obtained with mutant ∆viscB -P450 (data not shown). Open squares: L. bicolor S238N alone, black squares: L. bicolor S238N co-cultivated with P. fluorescens BBc6R8 WT, grey triangles: L. bicolor S238N co-cultivated with ∆ viscB. Each point is the mean value of 7 biological replicates +/- SD. The experiment was reproduced three times independently and similar results were obtained each time.

Reference spectrum [M+H] + Acquired spectrum m/z Relative abundance Supplemental Figure 7. Top panel: MS/MS spectrum for the [M+H] + ion identified as desferrioxamine E, bottom panel: reference MS/MS spectrum of desferrioxamine E from GNPS database.